Novavax Medical Information

DISCLAIMER: THIS PAGE IS INTENDED FOR HEALTHCARE PROFESSIONALS IN France ONLY.

If you are NOT a Healthcare Professional in France, please switch to the Consumer Medical Information page.

Information on the NuvaxovidTM XBB.1.5 ▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601)

If your enquiry is regarding the NuvaxovidTM XBB.1.5 ▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2601), you can find some useful information in the resources below.

Request Medical Information

Healthcare Professionals may request medical information via ONE of the following ways:

Option 1: Complete and submit a Medical Information Request Form by clicking on the button below.

Request Medical Information

Option 2: Call +33 1 82 88 32 29 between 09:00–17:00.

Report an Adverse Event (AE)

If you are concerned about an adverse event, it should be reported to the National Agency for the Safety of Medicines and Health Products (ANSM) and network of Regional Pharmacovigilance Centers at https://fr.novavaxcovidvaccine.com/non-hcp. Alternatively, adverse events of serious concern in association with a Novavax product can be reported to Novavax Pharmacovigilance at +33 1 82 88 32 29 or via the Novavax Adverse Event Reporting Form.

Report a Product Quality Complaint

If you have a product quality complaint related to a physical issue with a Novavax product or its packaging, please call +33 1 82 88 32 29 between 09:00–17:00.